tiprankstipranks
Advertisement
Advertisement
Matinas BioPharma files $150M mixed securities shelf
PremiumThe FlyMatinas BioPharma files $150M mixed securities shelf
1M ago
Matinas BioPharma Faces NYSE American Listing Compliance Notice
Premium
Company Announcements
Matinas BioPharma Faces NYSE American Listing Compliance Notice
4M ago
Matinas BioPharma CEO Named Interim Chief Financial Officer
Premium
Company Announcements
Matinas BioPharma CEO Named Interim Chief Financial Officer
6M ago
Matinas BioPharma Amends Bylaws and Sets Annual Meeting
PremiumCompany AnnouncementsMatinas BioPharma Amends Bylaws and Sets Annual Meeting
1y ago
Matinas BioPharma files to sell 16.9M shares of common stock for holders
Premium
The Fly
Matinas BioPharma files to sell 16.9M shares of common stock for holders
1y ago
Matinas Biopharma Delays 10-K Filing
Premium
Company Announcements
Matinas Biopharma Delays 10-K Filing
1y ago
Matinas BioPharma Board Member Herbert Conrad Resigns
PremiumCompany AnnouncementsMatinas BioPharma Board Member Herbert Conrad Resigns
1y ago
Matinas BioPharma appoints Evelyn D’An to board of directors
Premium
The Fly
Matinas BioPharma appoints Evelyn D’An to board of directors
1y ago
Cadrenal Therapeutics CMO Douglas Losordo departs, James Ferguson succeeds
Premium
The Fly
Cadrenal Therapeutics CMO Douglas Losordo departs, James Ferguson succeeds
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100